nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
|
Prins, Robert M. |
|
2008 |
57 |
9 |
p. 1279-1289 |
artikel |
2 |
CD54 is a surrogate marker of antigen presenting cell activation
|
Sheikh, N. A. |
|
2008 |
57 |
9 |
p. 1381-1390 |
artikel |
3 |
Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design
|
Kmieciak, Maciej |
|
2008 |
57 |
9 |
p. 1391-1398 |
artikel |
4 |
Development of a Listeria monocytogenes based vaccine against prostate cancer
|
Shahabi, Vafa |
|
2008 |
57 |
9 |
p. 1301-1313 |
artikel |
5 |
Experimental manipulations of afferent immune responses influence efferent immune responses to brain tumors
|
Thomas, Diana L. |
|
2008 |
57 |
9 |
p. 1323-1333 |
artikel |
6 |
Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer
|
Tseng-Rogenski, Stephanie S. |
|
2008 |
57 |
9 |
p. 1357-1365 |
artikel |
7 |
Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer
|
Tseng-Rogenski, Stephanie S. |
|
|
57 |
9 |
p. 1357-1365 |
artikel |
8 |
High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-α in lung cancer
|
Baleeiro, R. B. |
|
2008 |
57 |
9 |
p. 1335-1345 |
artikel |
9 |
Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma
|
Wang, Wenjun |
|
2008 |
57 |
9 |
p. 1315-1321 |
artikel |
10 |
Investigation of the mechanisms of tissue factor-mediated evasion of tumour cells from cellular cytotoxicity
|
Li, Chao |
|
2008 |
57 |
9 |
p. 1347-1355 |
artikel |
11 |
Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
|
Toubaji, Antoun |
|
2008 |
57 |
9 |
p. 1413-1420 |
artikel |
12 |
Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007
|
Schirrmacher, V. |
|
2008 |
57 |
9 |
p. 1421-1427 |
artikel |
13 |
Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007
|
Schirrmacher, V. |
|
|
57 |
9 |
p. 1421-1427 |
artikel |
14 |
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model
|
Inoue, Hiroyuki |
|
2008 |
57 |
9 |
p. 1399-1411 |
artikel |
15 |
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
|
Madigan, Michele C. |
|
2008 |
57 |
9 |
p. 1367-1379 |
artikel |
16 |
Toll-like receptors expressed in tumor cells: targets for therapy
|
Yu, Li |
|
2008 |
57 |
9 |
p. 1271-1278 |
artikel |
17 |
Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses
|
Roux, Stephan |
|
2008 |
57 |
9 |
p. 1291-1300 |
artikel |